BHU Digital Repository

Quality Assessment of Some Brands of Ciprofloxacin and Levofloxacin Tablets Circulating in Karu Local Government Area of Nasarawa state, Nigeria.

Show simple item record

dc.contributor.author ALFA, John
dc.date.accessioned 2024-05-31T10:21:04Z
dc.date.available 2024-05-31T10:21:04Z
dc.date.issued 2023
dc.identifier.issn 0331 - 670X
dc.identifier.uri http://localhost:8080/xmlui/handle/123456789/1565
dc.description.abstract Background: Circulation of poor-quality drugs has dire consequences on the health of consumers. Introduction of branded generics to ensure availability and affordability has shown potential for spread of poor-quality drugs. In this study, quality assessment of some commonly marketed ciprofloxacin (500 mg) and levofloxacin (500 mg) tablet brands in Karu Local Government Area (LGA) of Nasarawa State, Nigeria was evaluated. Methods: Five tablet brands including an innovator, of either drug were sourced from 5 different Pharmacies in the LGA. Tablets were coded A1-A5 and B1-B5 for ciprofloxacin and levofloxacin brands respectively. Physical assessment of the tablets was done. Physico-mechanical properties, uniformity of weight, friability and disintegration time were also evaluated using pharmacopeia methods. In vitro dissolution was carried out and the profiles statistically analyzed using the similarity and difference factors in comparison with the innovator products. Results: All the tablets had uniform weights within official specification, diameter was between 16.37 and 19.44 mm. Friability values were between 0.01 and 0.06 %; within specification. Disintegration time for ciprofloxacin and levofloxacin tablets was within 1.23 - 7.20 min and 3.19 - 12.90 min respectively; all met the specification. All (100 %) the ciprofloxacin brands met pharmacopeia requirement for drug release while only 60 % of the levofloxacin brands met this requirement. Comparatively A4 with f2 value of 41.62 % may not be interchangeable with the innovator brand while brands B2 and B4 with f2 values of 53.40 and 53.03 % respectively may be interchanged with the innovator brand or with each other. Conclusion: All the tablet brands were found to have good mechanical properties but only 75 % of the ciprofloxacin and 50 % of the levofloxacin tablet brands were found to be interchangeable with the innovator drug brands. This calls for concern as it brings to question the possible interchangeability of these brands with the innovator. en_US
dc.publisher THE NIGERIAN JOURNAL OF PHARMACY en_US
dc.relation.ispartofseries Volume 57;No. 1
dc.subject Ciprofloxacin en_US
dc.subject Levofloxacin en_US
dc.subject Tablet Brands en_US
dc.subject Similarity Factor en_US
dc.subject Interchangeable en_US
dc.title Quality Assessment of Some Brands of Ciprofloxacin and Levofloxacin Tablets Circulating in Karu Local Government Area of Nasarawa state, Nigeria. en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search BHUDR


Advanced Search

Browse

My Account